Youtheory
US$ 21.96
foxo4 dri for senescent cells Development of a novel senolytic by precise disruption of FOXO4-p53 complex FOX04-DRI (Anti-Aging & Senescent Cell
Description
The information presented reflects clinical trial data available as of the publication date and may not reflect subsequent developments
Many adults do not produce sufficient butyrate due to diets low in the specific fibers and polyphenols that butyrate-producing bacteria require
: ,
The PL-10 trial (a phase 2 study for inflammatory bowel disease) was listed on registries but full peer-reviewed results were not published
Call us at 509.586.2828 to schedule an appointment today and experience the difference at Regenerative Orthopedic Solutions
